We Can Help

The costs of mesothelioma can be overwhelming. They can include income loss, expensive treatments that may not be covered by health insurance, plus pain and suffering for you and for your family. Because the disease is preventable – and because it is usually caused by someone else’s negligence – legal options may be available to help regain these costs. Asbestos lawyers focus their practice on knowledgeably and effectively bringing to justice companies that exposed employees and the public to asbestos products. A mesothelioma attorney can help you consider your options and file a claim against the company responsible for your asbestos-related illness. More than one company may be responsible. A mesothelioma attorney identifies all companies at fault. Mesothelioma lawsuits have helped thousands of people receive financial assistance. A lawsuit can result in much-needed money to help reduce financial hardships during an illness and can also provide a more stable future for your loved ones. A lawyer specializing in asbestos litigation can help you seek compensation for expenses related to illness caused by asbestos exposure.

Promising Clinical Trial Results For A Mesothelioma Immunotherapy Drug

Promising results from another phase of a clinical trial for an immunotherapy drug for mesothelioma, CRS-207, have been released. […]

Promising Lung Cancer Vaccine From Cuba At Roswell Park Cancer Institute

Roswell Park Cancer Institute is working on a promising lung cancer vaccine from Cuba that will be submitted for FDA approval. […]

FDA-Approved Keytruda Treatment Could Help Mesothelioma Patients

Recently, the FDA approved Merck immunotherapy drug Keytruda for treatment in non-small cell lung cancer and is bringing hope to mesothelioma patients. […]

New Mesothelioma Treatment Receives FDA Orphan Drug Designation

A new drug has been granted Orphan Drug Status by the US FDA as a potentially safe and effective treatment for mesothelioma cancer. […]

FDA Grants AstraZeneca’s Tremelimumab Orphan Drug Status for Mesothelioma

AstraZeneca’s tremelimumab (anti-CTLA-4 monoclonal antibody) has received Orphan Drug status from the FDA for treating malignant mesothelioma. […]

Can Opdivo Drug Be Good News for Mesothelioma Patients?

Expanded approved use of new lung cancer drug Opdivo could give malignant pleural mesothelioma patients hope. […]

Mesothelioma Advocate Max Baucus Leaving U.S. Senate

Max Baucus leaving U.S. Senate leaves the mesothelioma and asbestos community without one of its strongest supporters […]